Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
about
Human monocyte Arg-Serpin cDNA. Sequence, chromosomal assignment, and homology to plasminogen activator-inhibitorFacultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2Secretory products of macrophages.Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoterPhorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitorPlasminogen activator-specific inhibitors produced by human monocytes/macrophages.Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.Alpha 2-macroglobulin restricts plasminogen activation to the surface of RC2A leukemia cells.Association between alveolar macrophage plasminogen activator activity and indices of lung function in young cigarette smokers.Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts.Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.
P2860
Q24682654-10D91D8E-EAE3-4570-98DF-BF7F5D2F97B5Q33584270-D136AC68-6410-4A9C-84EA-B2E000AAF64CQ34557411-C451D37E-5885-40E6-A429-94E205C2C8B1Q34996841-08A0055E-2A42-44F6-92FC-13434D2B59B9Q35772792-1749F5CE-D6AC-4624-8277-5B84111AECE0Q36216416-A9F7EB1E-7AC6-45D4-ACF6-5869172FF5C8Q36218668-CE7349F7-10A0-4E57-BCDD-D3EA6022E770Q36223687-6C5378DC-B5B5-4B65-BF53-1145AE690B09Q36351900-C6EE2C27-0483-483D-A826-A1D381EDBA48Q36353359-426A0EFA-0C04-40C0-B827-1AFDD6CD48D9Q36920255-24825087-9321-4999-9E16-4AD4DC5AEA6FQ39508019-A59C12E5-A43F-4AB8-A9AF-EAB5ADD89BF8Q40642976-1DB0D747-FB0C-4BBF-AF31-679E6C02AFA2Q41260460-383CD759-BD13-4F2B-9047-F157D44840FAQ41362675-F328A290-8881-4008-B089-9D97388C8251Q48354717-045A4B73-0879-48EE-8444-EFC245E9772B
P2860
Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Characterization of a macropha ...... placental urokinase inhibitor.
@en
Characterization of a macropha ...... placental urokinase inhibitor.
@nl
type
label
Characterization of a macropha ...... placental urokinase inhibitor.
@en
Characterization of a macropha ...... placental urokinase inhibitor.
@nl
prefLabel
Characterization of a macropha ...... placental urokinase inhibitor.
@en
Characterization of a macropha ...... placental urokinase inhibitor.
@nl
P2860
P356
P1433
P1476
Characterization of a macropha ...... placental urokinase inhibitor.
@en
P2093
H A Chapman
P2860
P304
P356
10.1042/BJ2300109
P407
P577
1985-08-01T00:00:00Z